Annual Drug Patent Expirations for TIBSOVO
Tibsovo is a drug marketed by Agios Pharms Inc and is included in one NDA. There are five patents protecting this drug.
This drug has eigthy-five patent family members in thirty-four countries.
The generic ingredient in TIBSOVO is ivosidenib. Additional details are available on the ivosidenib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
